-
Nippon India Pharma Fund - Growth
Equity healthcare
Overview ( as on 04/07/25 )
NAV
₹522.75
Last change
₹2.89 +0.01%
Fund Size (AUM)
8352.16 Cr
Performance
22.44% (5Y)
Fund Details
Nippon India Pharma Fund - Growth
as of 04/07/25
AUM
8352.16 Cr
Expense Ratio
1.8 %
Benchmark
BSE Healthcare TR INR
ISIN
INF204K01968
Fund Manager
Sailesh Raj Bhan
Exit Load
1.0% if redeemed within 0-1 months
0% if redeemed after 1 months
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Nippon India Pharma Fund - Growth | 15.02% | 25.79% | 22.44% |
| BSE Healthcare TR INR | 19.26% | 27.0% | 22.17% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
12.57% |
Divi's Laboratories Ltd |
9.49% |
Lupin Ltd |
5.82% |
Cipla Ltd |
5.62% |
Dr Reddy's Laboratories Ltd |
5.49% |
Apollo Hospitals Enterprise Ltd |
5.34% |
Medplus Health Services Ltd |
4.2% |
GlaxoSmithKline Pharmaceuticals Ltd |
3.73% |
Vijaya Diagnostic Centre Ltd |
3.24% |
Narayana Hrudayalaya Ltd |
2.94% |
Sector Allocation
Healthcare |
100.0% |
Asset Allocation
-
99%
Equity
-
1%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
24.94% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
24.69% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
24.69% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
22.2% (5Y)
-
-
UTI Healthcare Reg Gr
Equity healthcare-
Returns
-
22.56% (5Y)
-
-
UTI Healthcare Reg IDCW-P
Equity healthcare-
Returns
-
22.56% (5Y)
-
